192 related articles for article (PubMed ID: 25111485)
1. DNA methylation markers for early detection of women's cancer: promise and challenges.
Wittenberger T; Sleigh S; Reisel D; Zikan M; Wahl B; Alunni-Fabbroni M; Jones A; Evans I; Koch J; Paprotka T; Lempiäinen H; Rujan T; Rack B; Cibula D; Widschwendter M
Epigenomics; 2014 Jun; 6(3):311-27. PubMed ID: 25111485
[TBL] [Abstract][Full Text] [Related]
2. Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.
Jones A; Lechner M; Fourkala EO; Kristeleit R; Widschwendter M
Epigenomics; 2010 Feb; 2(1):9-38. PubMed ID: 22122746
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
5. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
7. Research project will use cervical cells to predict risk of cancers.
Torjesen I
BMJ; 2015 Jun; 350():h2999. PubMed ID: 26037736
[No Abstract] [Full Text] [Related]
8. [Tumor markers in gynecological and breast cancer].
Jobo T; Sato R; Kuramoto H
Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine: present and future of breast cancer management.
Sabatier R; Gonçalves A; Bertucci F
Crit Rev Oncol Hematol; 2014 Sep; 91(3):223-33. PubMed ID: 24725667
[TBL] [Abstract][Full Text] [Related]
10. Use of DNA methylation for cancer detection: promises and challenges.
Zhu J; Yao X
Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
[TBL] [Abstract][Full Text] [Related]
11. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
13. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
Ambeba E; Linkov F
Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
Cronin M; Ross JS
Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
[TBL] [Abstract][Full Text] [Related]
15. Methylation-based analysis of circulating DNA for breast tumor screening.
Rykova EY; Tsvetovskaya GA; Sergeeva GI; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():232-5. PubMed ID: 18837953
[TBL] [Abstract][Full Text] [Related]
16. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA.
Zhang Q; Hu G; Yang Q; Dong R; Xie X; Ma D; Shen K; Kong B
Gynecol Oncol; 2013 Jul; 130(1):132-9. PubMed ID: 23623832
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
[TBL] [Abstract][Full Text] [Related]
18. Personalized therapy for breast cancer: a dream or a reality?
Zardavas D; Pugliano L; Piccart M
Future Oncol; 2013 Aug; 9(8):1105-19. PubMed ID: 23902243
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
